Want to see CH:SFZN full AI Analyst Report?
SFZN Stock Chart & Stats
CHF70.70
CHF1.25(1.77%)
At close: 4:00 PM EDT
CHF70.70
CHF1.25(1.77%)
Day’s Range― - ―
52-Week RangeCHF65.05 - CHF101.60
Previous CloseN/A
Volume13.31K
Average Volume (3M)101.52K
Market Cap
CHF3.42B
Enterprise ValueCHF3.73K
Total Cash (Recent Filing)CHF103.80M
Total Debt (Recent Filing)CHF575.20M
Price to Earnings (P/E)19.7
Beta0.90
Next Earnings
Aug 21, 2026EPS Estimate
1.59Next Dividend Ex-DateN/A
Dividend Yield0.53%
Share Statistics
EPS (TTM)3.85
Shares Outstanding45,230,000
10 Day Avg. Volume105,249
30 Day Avg. Volume101,518
Financial Highlights & Ratios
PEG Ratio5.13
Price to Book (P/B)2.89
Price to Sales (P/S)2.46
P/FCF Ratio327.33
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF81.67Price Target Upside15.51% Upside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)4.09
Revenue Forecast (FY)CHF1.41B
Bulls Say, Bears Say
Bulls Say
Financial PositionSFZN's balance sheet is seen as healthy, which supports potential US expansion and merger or acquisition activities.
Operational EfficiencyEBITDA margins are anticipated to increase, reflecting a positive outlook on operational efficiency.
TariffsAnalyst highlights SFZN's low exposure to tariffs and potential volume share gains in generics at the expense of Chinese and Indian competitors.
Bears Say
Market OutlookThe first half of the year is expected to be weaker, which may put pressure on achieving an acceleration in the second half.
Profit MarginsAnalyst notes that generics are hit harder by tariffs compared to exclusive contracts, potentially impacting profit margins.
Stock PerformanceThe company is expected to face near-term pressure with limited catalysts for stock improvement in the first half of the year.
Siegfried Holding AG News
SFZN FAQ
What was Siegfried Holding AG’s price range in the past 12 months?
Siegfried Holding AG lowest stock price was CHF65.05 and its highest was CHF101.60 in the past 12 months.
What is Siegfried Holding AG’s market cap?
Siegfried Holding AG’s market cap is CHF3.42B.
When is Siegfried Holding AG’s upcoming earnings report date?
Siegfried Holding AG’s upcoming earnings report date is Aug 21, 2026 which is in 17 days.
How were Siegfried Holding AG’s earnings last quarter?
Siegfried Holding AG released its earnings results on Feb 20, 2026. The company reported CHF2.2 earnings per share for the quarter, beating the consensus estimate of CHF2.167 by CHF0.033.
Is Siegfried Holding AG overvalued?
According to Wall Street analysts Siegfried Holding AG’s price is currently Undervalued.
Does Siegfried Holding AG pay dividends?
Siegfried Holding AG pays a Annually dividend of CHF0.4 which represents an annual dividend yield of 0.53%. See more information on Siegfried Holding AG dividends here
What is Siegfried Holding AG’s EPS estimate?
Siegfried Holding AG’s EPS estimate is 1.59.
How many shares outstanding does Siegfried Holding AG have?
Siegfried Holding AG has 45,230,000 shares outstanding.
What happened to Siegfried Holding AG’s price movement after its last earnings report?
Siegfried Holding AG reported an EPS of CHF2.2 in its last earnings report, beating expectations of CHF2.167. Following the earnings report the stock price went down -8.778%.
Which hedge fund is a major shareholder of Siegfried Holding AG?
Currently, no hedge funds are holding shares in CH:SFZN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Siegfried Holding AG
Siegfried Holding AG (SFZN) is a Switzerland-based contract development and manufacturing organization (CDMO) serving the pharmaceutical industry. The company provides integrated services spanning the development and commercial manufacture of drug substances (active pharmaceutical ingredients, including small molecules and some controlled substances) and drug products (finished dosage forms such as tablets, capsules, and other oral solids). Siegfried operates manufacturing and development sites in Europe and North America and supports both originator (innovative) and generic pharmaceutical customers.
SFZN Stock 12 Month Forecast
Average Price Target
CHF81.67
▲(15.51% Upside)
Technical Analysis
Lonza Group Ltd
―
Bachem Holding AG
―
PolyPeptide Group AG
―
Sandoz Group Ltd
―
Galenica AG
―







